M.D. Anderson Cancer Center: all 3,044 studies

Page 25 of 31. Open to participants first (578), then studies with results posted, then the rest; newest registration first within each.

• Hepatic Arterial Infusion Oxaliplatin, Capecitabine With or Without BevacizumabCompletedNCT01213238Phase 1
• Vaccine Therapy in Treating Patients With Lymphoplasmacytic LymphomaCompletedNCT01209871Phase 1
• Evaluation of Antiproliferative Effects of Arimidex in Ductal Lavage Fluid in Patients With Breast CancerCompletedNCT01207635
• Evaluation of the Molecular Effects of Metformin on the Endometrium in Patients With Endometrial CancerCompletedNCT01205672Early Phase 1
• Relaxation for Women With Breast Cancer Undergoing RadiotherapyActive, not recruitingNCT01202851Phase 3
• Phase I Study of Surface-Controlled Water Soluble Curcumin (THERACURMIN CR-011L)CompletedNCT01201694Phase 1
• Rocking Motion: Physiologic Effect on the Surgical Stress ResponseCompletedNCT01200316Phase 1
• Study of Grifola Frondosa (Maitake), Azacitidine, and LenalidomideTerminatedNCT01200004Phase 1
• Hormone Receptor Positive Disease Across Solid Tumor Types: A Phase I Study of Single-Agent Hormone Blockade and Combination Approaches With Targeted Agents to Provide Synergy and Overcome ResistanceCompletedNCT01197170Phase 1
• Colorectal Cancer Umbrella Protocol - Assessment of Targeted Therapies Against Colorectal Cancer (ATTACC Program) Screening ProtocolCompletedNCT01196130
• Social Contextual Influences on Physical ActivityStatus unknownNCT01195337
• Symptom Burden in Patients With Cancer- and Treatment-Related Skin ProblemsTerminatedNCT01193036
• SCH-900105 in Recurrent GlioblastomaWithdrawnNCT01189513Phase 1
• Phase I Trial of Bevacizumab and Temsirolimus in Combination With 1) Carboplatin, 2) Paclitaxel, 3) Sorafenib for the Treatment of Advanced CancerActive, not recruitingNCT01187199Phase 1
• Multimedia Patient EducationCompletedNCT01184534
• Lenalidomide in Combination With Bevacizumab, Sorafenib, Temsirolimus, or 5-Fluorouracil, Leucovorin, Oxaliplatin (FOLFOX)CompletedNCT01183663Phase 1
• Symptom Inventory for Gastrointestinal Stromal TumorsStatus unknownNCT01178307
• Trientine and Carboplatin in Advanced MalignanciesCompletedNCT01178112Phase 1
• Yttrium Y 90 Glass Microspheres in Treating Patients With Unresectable Hepatocellular CarcinomaCompletedNCT01176604Not applicable
• Study of Hypofractionated Proton Radiation Therapy in Thoracic MalignanciesTerminatedNCT01165658Phase 1
• 1B Intravesical Administration of SCH 721015 (Ad-IFNa) in Admixture With SCH 209702 (Syn3) for The Treatment of BCG Refractory Superficial Bladder CancerCompletedNCT01162785Phase 1
• Molecular Triaging of Newly Diagnosed Breast CancerWithdrawnNCT01159236Not applicable
• Paclitaxel, Carboplatin and Cetuximab (PCC) With Cetuximab, Docetaxel, Cisplatin and Fluorouracil (C-TPF) in Previously Untreated Patients With Locally Advanced Head and Neck Squamous Cell CarcinomaActive, not recruitingNCT01154920Phase 2
• Bendamustine and Bevacizumab for Advanced CancersCompletedNCT01152203Phase 1
• FLT-PET as an Imaging Biomarker With Temsirolimus, Topotecan, and BortezomibCompletedNCT01143779Phase 1
• 4'-Thio-araC (Thiarabine) in Advanced Hematologic MalignanciesCompletedNCT01139151Phase 1
• Radical Pleurectomy/Decortication (PD) and Intensity Modulated Radiotherapy (IMRT)CompletedNCT01134146Phase 1
• Survivorship in Lynch Syndrome FamiliesCompletedNCT01126840
• Sunitinib Plus Temsirolimus in Patients With Renal Cell Cancer (RCC)CompletedNCT01122615Phase 1
• Pleural Catheters Versus Thoracoscopic PleurodesisCompletedNCT01117740
• Nab-paclitaxel, Gemcitabine, and Bevacizumab in Advanced MalignanciesCompletedNCT01113476Phase 1
• Rituximab Maintenance After Autologous TransplantationTerminatedNCT01103388Phase 3
• Simultaneous Integrated Boost (SIB) in Esophageal CancerCompletedNCT01102088Phase 1
• Antimicrobial Solution or Saline Solution in Maintaining Catheter Patency and Preventing Catheter-Related Blood Infections in Patients With MalignanciesWithdrawnNCT01101412Phase 1/2
• Smoking Cessation Treatment for Head & Neck Cancer PatientsActive, not recruitingNCT01098955Early Phase 1
• Fluorescent Dyes for Lymph Node MappingCompletedNCT01095913Phase 1
• Pharmacokinetic (PK) and Pharmacodynamic (PD) Study of Nelarabine in Patients With Relapsed/Refractory Lymphoid MalignanciesCompletedNCT01094860Phase 1
• Late Chronic Phase Chronic Myelogenous LeukemiaCompletedNCT01092741Phase 2
• Lapatinib With Sirolimus or MetforminCompletedNCT01087983Phase 1
• Sirolimus or Everolimus or Temsirolimus and Vorinostat in Advanced CancerActive, not recruitingNCT01087554Phase 1
• Imatinib Mesylate and Docetaxel in Non-Small Cell Lung Cancer (NSCLC)CompletedNCT01083589Phase 2
• A Phase I Study of TPI 287 - Temozolomide Combination in MelanomaTerminatedNCT01067066Phase 1
• HAI Abraxane With Gemcitabine and BevacizumabCompletedNCT01057264Phase 1
• Docetaxel and Sirolimus in Patients With Advanced MalignanciesCompletedNCT01054313Phase 1
• Reducing Symptom Burden - Non Small Cell Lung Cancer (NSCLC)WithdrawnNCT01048983Phase 1/2
• Symptom Burden in Chronic Myeloid Leukemia (CML)Status unknownNCT01046305
• Study of Weekly LOC-paclitaxel Injection for MelanomaTerminatedNCT01039844Phase 1
• TMC (Topotecan, Cyclophosphamide and Melphalan) for Multiple MyelomaCompletedNCT01039025Phase 2
• M. D. Anderson Symptom Inventory - Ovarian CancerCompletedNCT01037751
• Chlorhexidine Gel Therapy for Cariogenic Oral MicrofloraCompletedNCT01036412Phase 1
• Effectiveness of Using Biomarkers to Detect and Identify Cardiotoxicity and Describe Treatment (PREDICT)Status unknownNCT01032278Not applicable
• Assessment of Sexual Dysfunction, Depression and Anxiety in Underserved, Minority Gynecologic Cancers PatientsCompletedNCT01031602
• Comparison of PEM Uptake Value (PUV) and Standardized Uptake Value (SUV) in Patients With Malignancies of the BreastCompletedNCT01031238
• Detection of Cervical Lymph Node Metastases With a High-Resolution Positron Emission Tomography (PET) Imaging SystemCompletedNCT01030497
• Study to Assess OPB-31121 in Advanced Leukemias or Myelodysplastic SyndromesTerminatedNCT01029509Phase 1
• Patient-Reported Outcomes-Based Palliative and Hospice Care Practice: A Usability StudyCompletedNCT01024166
• Chemotherapy-Induced Peripheral Neuropathy SurveyWithdrawnNCT01016028
• Dasatinib, Bevacizumab, Paclitaxel in Patients With Advanced MalignanciesCompletedNCT01015222Phase 1
• Physician Perceptions About Parenteral Hydration in Latin America and SpainStatus unknownNCT01011140
• Feasibility Study for Imaging of Peripheral Tumors With a High-Resolution PET Imaging SystemCompletedNCT01008930Not applicable
• Motivational Interviewing for Physical ActivityActive, not recruitingNCT01008787Not applicable
• Markers of Response to Intravesical Bladder Cancer TherapyCompletedNCT01007058
• Interstitial Fluid Pressure (IFP) Pilot Study in Melanoma PatientsWithdrawnNCT01003626Not applicable
• Autologous Transplantation for Chronic Myelogenous LeukemiaCompletedNCT01003054Phase 2
• Doctor-Recommended Home-Based Exercise Program or Relaxation Training in Improving Physical Function and Controlling Symptoms in Patients With Stage IV or Recurrent Colon Cancer That Cannot Be Removed By SurgeryStatus unknownNCT00985400Not applicable
• Combined Modality Treatment for Resectable Non-Small Cell Superior Sulcus TumorsCompletedNCT00984997Phase 2
• Reducing Tobacco Related Health DisparitiesCompletedNCT00984724Not applicable
• Celecoxib as a Chemopreventive Agent in Current and Former SmokersCompletedNCT00981201Phase 3
• HAI Irinotecan + IV Bevacizumab, Bevacizumab & Oxaliplatin or Bevacizumab & Cetuximab in Advanced Cancers Metastatic to LiverCompletedNCT00980239Phase 1
• Infusion of Expanded Cord Blood T CellsWithdrawnNCT00972101Phase 1
• Discount Generic Prescription StudyCompletedNCT00971022
• Cisplatin, Temozolomide, Abraxane, With Interleukin-2 and Interferon for Metastatic MelanomaCompletedNCT00970996Phase 1
• Trial of Curcumin in Cutaneous T-cell Lymphoma PatientsWithdrawnNCT00969085Phase 2
• CD19-specific T Cell Infusion in Patients With B-Lineage Lymphoid MalignanciesCompletedNCT00968760Phase 1
• C-VISA BikDD: Liposome in Advanced Pancreatic CancerWithdrawnNCT00968604Phase 1
• Study of Phenethyl Isothiocyanate in Lymphoproliferative DisordersWithdrawnNCT00968461Phase 1
• Ex-Vivo Depletion of Myeloma Cells From Peripheral Blood Progenitor Cell GraftsWithdrawnNCT00968396Phase 2
• Caphosol in Sarcoma Patients With MucositisCompletedNCT00965172Phase 2
• Reactogenicity, Immunogenicity of Trivalent Influenza Vaccine With Recombinant Interferon Alpha Among Chronic Lymphocytic LeukemiaWithdrawnNCT00962715Phase 1/2
• NOV-002 in Myelodysplastic Syndrome (MDS)WithdrawnNCT00960726Phase 2
• Correlation of Genomic Variation in Enzymes Responsible for Metabolism of Capecitabine With Drug MetabolismWithdrawnNCT00960544Phase 2
• Cidofovir Instillation in Hematopoietic Stem Cell Transplant (HSCT) Recipients With Hemorrhagic CystitisWithdrawnNCT00956176Not applicable
• STAT3 Inhibitor for Solid TumorsCompletedNCT00955812Phase 1
• Phase Ib Study of Erlotinib Prior to Surgery in Patients With Head and Neck CancerCompletedNCT00954226Phase 1
• Complete Decongestive Therapy (CDT) for Treatment of Head and Neck LymphedemaWithdrawnNCT00951470Not applicable
• Stereotactic Radiosurgery Compared to Observation in Treating Patients With Brain MetastasesActive, not recruitingNCT00950001Phase 3
• Complementary and Alternative Medicine Usage Among Participants Enrolled in Phase I Oncology Clinical TrialsCompletedNCT00949390
• Project COMBAT: Combating Tobacco Use in the United States ArmyWithdrawnNCT00948233
• Mobile Smoking Cessation Intervention in Enhancing Cancer Outreach in Low-Income Adult SmokersCompletedNCT00948129Not applicable
• Outpatient Neutropenic Diet StudyTerminatedNCT00947648Phase 2
• Granulocyte-colony Stimulating Factor (G-CSF) and Plerixafor Plus Sorafenib for Acute Myelogenous Leukemia (AML) With FLT3 MutationsCompletedNCT00943943Phase 1
• Hepatic Arterial Infusion Oxaliplatin + 5FU, Leucovorin, and Bevacizumab +/- CetuximabCompletedNCT00941499Phase 1
• Enhanced Smoking Cessation for University StudentsCompletedNCT00941395Not applicable
• Sirolimus and Cetuximab in Advanced MalignanciesCompletedNCT00940381Phase 1
• TTP607 in Refractory Solid MalignanciesWithdrawnNCT00939172Phase 1
• Lenalidomide and Paclitaxel in Prostate CancerTerminatedNCT00933426Phase 1
• The Impact of Obesity and Obesity Treatments on Breast CancerCompletedNCT00933309Phase 1
• Aggressive Local Therapy for Limited Bone-Only Metastasis to Improve Progression-Free Survival in Breast Cancer PatientsActive, not recruitingNCT00929214Phase 2
• Reflux Disease in Head and Neck Cancer Patients Undergoing Radiation TherapyWithdrawnNCT00928161Not applicable
• Cancer Patients Diagnosed With Unsuspected Venous Thromboembolism (VTE) on Routine Computed Tomography (CT) ScansStatus unknownNCT00925808

← M.D. Anderson Cancer Center overview and focus areas